scholarly journals Characteristic Distribution of Hematopoietic Cells in Bone Marrow of Xenopus Laevis

Author(s):  
Sumiharu Morita ◽  
Takeshi Moriishi ◽  
Satoru Matsunaga ◽  
Kei Kitamura ◽  
Shin-ichi Abe ◽  
...  
Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 4577-4577
Author(s):  
Takehito Okui ◽  
Yusuke Yamamoto ◽  
Youichi Aizawa ◽  
Takashi Kato

Abstract Abstract 4577 In mammalians, primitive hematopoiesis occurs in yolk sac at early embryonic, and alters to a liver and spleen turning to definitive hematopoiesis at fetal stage. And then, finally, bone marrow becomes a main hematopoietic organ in adult. In contrast, adipocytes and fat fill the bone marrow in African clawed frog Xenopus laevis, limiting the space available for generating red blood cells. This prompted us to look at blood formation in other organs including liver, lung, kidney, and spleen. From previous reports of morphological observations and results of in vitro colony-forming units assay, it is considered that many of erythroid cells exist in the liver, and thrombocytic and leukocytic cells mainly exist in the spleen or the bone marrow. This indicates that blood cells of frogs are produced in different organ attending to blood cell kinds and it is seemed that frogs are favorable to investigate microenvironments proper to each blood cell kinds. Here, we used a progenitor assay based on label retention of thymidine analog 5-bromo-2′-deoxyuridine (BrdU) in frogs with phenylhydrazine (PHZ)-induced acute hemolytic anemia and those with phlebotomy-caused anemia. We gave sub-lethal, intraperitoneal doses of PHZ (25 mg/Kg) to adult frogs and injected BrdU (170 mg/Kg) after seven days to trace proliferating cells in each organ. One week later, we found significant increases in the number of BrdU-positive cells in liver, lung, kidney and spleen compared to controls. To role out the possibility that BrdU was incorporated in non-hematopoietic cells of tissues, especially damaged by PHZ administration, we also examined phlebotomy-caused anemic model. Though the number of BrdU-positive cells are less than PHZ administrated frog, two days of phlebotomy similarly increased the number of BrdU-positive cells in those tissues. These results indicated that, in anemic condition, proliferating cells were resided in liver, lung, spleen and kidney. We also localized slow cycling, immature cells. Twenty-five days after BrdU injection, few labeled cells remained in the tissues, so we re-injected PHZ to induce acute hemolytic anemia again. Eight days later, BrdU-positive cells reappeared but only in liver, suggesting that progenitor cells divided during the second PHZ-induced anemia. In control frogs that did not receive a second PHZ injection, BrdU-positive cells were still present in liver after seventy days. In adult liver, histochemistry revealed BrdU-positive cells with the morphological appearance of hematopoietic cells. Immunostaining with polyclonal anti-Xenopus laevis erythropoietin receptor (xlEPOR) antibody further suggested the presence of erythropoiesis. This observation led us to examine where erythroid progenitor cells locate in the liver and what kinds of cells exist around them to support erythropoiesis. The localization of hepatocytes, kupffer cells and vascular endothelial cells were visualized, by detecting with in situ hybridization for albumin, use of carmine phagocytosis and lectin labeling, respectively. Furthermore transmission electron microscopy confirmed the ultrastructure of these cells. Based on morphological analysis, we showed the localization of erythroid cells in the liver spatially and its time-dependent change through becoming anemia. In the mammalian liver, erythropoiesis occurs during fetal development or as extramedullary hematopoiesis. Our findings may offer a new model for analyzing red blood cell formation in the hepatic microenvironment in response to anemia. Disclosures: No relevant conflicts of interest to declare.


Leukemia ◽  
2021 ◽  
Author(s):  
Melvin E. Thomas ◽  
Sherif Abdelhamed ◽  
Ryan Hiltenbrand ◽  
Jason R. Schwartz ◽  
Sadie Miki Sakurada ◽  
...  

AbstractPediatric myelodysplastic syndromes (MDS) are a heterogeneous disease group associated with impaired hematopoiesis, bone marrow hypocellularity, and frequently have deletions involving chromosome 7 (monosomy 7). We and others recently identified heterozygous germline mutations in SAMD9 and SAMD9L in children with monosomy 7 and MDS. We previously demonstrated an antiproliferative effect of these gene products in non-hematopoietic cells, which was exacerbated by their patient-associated mutations. Here, we used a lentiviral overexpression approach to assess the functional impact and underlying cellular processes of wild-type and mutant SAMD9 or SAMD9L in primary mouse or human hematopoietic stem and progenitor cells (HSPC). Using a combination of protein interactome analyses, transcriptional profiling, and functional validation, we show that SAMD9 and SAMD9L are multifunctional proteins that cause profound alterations in cell cycle, cell proliferation, and protein translation in HSPCs. Importantly, our molecular and functional studies also demonstrated that expression of these genes and their mutations leads to a cellular environment that promotes DNA damage repair defects and ultimately apoptosis in hematopoietic cells. This study provides novel functional insights into SAMD9 and SAMD9L and how their mutations can potentially alter hematopoietic function and lead to bone marrow hypocellularity, a hallmark of pediatric MDS.


2021 ◽  
pp. 102341
Author(s):  
Rina Otsuka-Yamaguchi ◽  
Masaaki Kitada ◽  
Yasumasa Kuroda ◽  
Yoshihiro Kushida ◽  
Shohei Wakao ◽  
...  

Blood ◽  
1997 ◽  
Vol 89 (11) ◽  
pp. 3919-3924 ◽  
Author(s):  
Jean C.Y. Wang ◽  
Monica Doedens ◽  
John E. Dick

Abstract We have previously reported the development of in vivo functional assays for primitive human hematopoietic cells based on their ability to repopulate the bone marrow (BM) of severe combined immunodeficient (SCID) and nonobese diabetic/SCID (NOD/SCID) mice following intravenous transplantation. Accumulated data from gene marking and cell purification experiments indicate that the engrafting cells (defined as SCID-repopulating cells or SRC) are biologically distinct from and more primitive than most cells that can be assayed in vitro. Here we demonstrate through limiting dilution analysis that the NOD/SCID xenotransplant model provides a quantitative assay for SRC. Using this assay, the frequency of SRC in cord blood (CB) was found to be 1 in 9.3 × 105 cells. This was significantly higher than the frequency of 1 SRC in 3.0 × 106 adult BM cells or 1 in 6.0 × 106 mobilized peripheral blood (PB) cells from normal donors. Mice transplanted with limiting numbers of SRC were engrafted with both lymphoid and multilineage myeloid human cells. This functional assay is currently the only available method for quantitative analysis of human hematopoietic cells with repopulating capacity. Both CB and mobilized PB are increasingly being used as alternative sources of hematopoietic stem cells in allogeneic transplantation. Thus, the findings reported here will have important clinical as well as biologic implications.


2021 ◽  
Vol 7 (1) ◽  
pp. 11
Author(s):  
Jaromír Vašíček ◽  
Andrej Baláži ◽  
Miroslav Bauer ◽  
Andrea Svoradová ◽  
Mária Tirpáková ◽  
...  

Hematopoietic stem and progenitor cells (HSC/HPCs) of human or few animal species have been studied for over 30 years. However, there is no information about rabbit HSC/HPCs, although they might be a valuable animal model for studying human hematopoietic disorders or could serve as genetic resource for the preservation of animal biodiversity. CD34 marker is commonly used to isolate HSC/HPCs. Due to unavailability of specific anti-rabbit CD34 antibodies, a novel strategy for the isolation and enrichment of rabbit HSC/HPCs was used in this study. Briefly, rabbit bone marrow mononuclear cells (BMMCs) were sorted immunomagnetically in order to remove all mature (CD45+) cells. The cells were depleted with overall purity about 60–70% and then cultured in a special medium designed for the expansion of CD34+ cells. Quantitative Polymerase Chain Reaction (qPCR) analysis confirmed the enrichment of primitive hematopoietic cells, as the expression of CD34 and CD49f increased (p < 0.05) and CD45 decreased (p < 0.001) at the end of culture in comparison to fresh BMMCs. However, cell culture still exhibited the presence of CD45+ cells, as identified by flow cytometry. After gating on CD45− cells the MHCI+MHCII−CD38+CD49f+CD90−CD117− phenotype was observed. In conclusion, rabbit HSC/HPCs might be isolated and enriched by the presented method. However, further optimization is still required.


2001 ◽  
Vol 125 (2) ◽  
pp. 198-201
Author(s):  
Geza Acs ◽  
Virginia A. LiVolsi

Abstract Context.—The special societal relationships existing between various cell types in bone marrow suggests that there may be a link between the adhesive characteristics of hematopoietic cells and their maturation. Egress of the developing hematopoietic cells is also a highly regulated process governed by adhesive interactions. In leukemia, immature blasts are not retained within the marrow, suggesting a breakdown of adhesive mechanisms. Recent reports suggest that E-cadherin, an epithelial adhesion molecule, is expressed on erythroid precursors and megakaryocytes, but not on other hematopoietic marrow elements. Objective.—To characterize the expression pattern of E-cadherin in normal and leukemic erythroid precursors by immunohistochemistry in paraffin-embedded tissue and bone marrow aspirate smears. Methods.—Five normal bone marrow specimens from rib resections, 15 trephine bone marrow biopsy specimens, and 6 bone marrow aspirate smears from the iliac crest of patients with no known leukemia were selected. Fourteen bone marrow biopsy specimens from patients with erythroleukemia were also studied. Immunoperoxidase staining of paraffin-embedded tissue and air-dried aspirate smears for E-cadherin (1:200 dilution, HECD-1 clone) was performed using the avidin-biotin peroxidase technique. Results.—In paraffin-embedded bone marrow biopsy and rib specimens and in air-dried bone marrow aspirate smears, strong membrane expression of E-cadherin was seen in the normal erythroid precursors in all cases. In contrast, no membrane expression of E-cadherin was present in any of the bone marrow biopsy specimens from patients with erythroleukemia. Conclusions.—Immunohistochemical detection of membrane expression of E-cadherin may be a useful tool for identification of erythroid precursors. Cells of erythroleukemia lack membrane expression of E-cadherin, in contrast to their normal counterparts. Further studies are needed to define the potential role of E-cadherin in the maturation of erythroid precursors and to ascertain the significance of loss of membrane expression of E-cadherin in erythroleukemia.


2017 ◽  
Vol 191 ◽  
pp. 44-50
Author(s):  
Abubakar Garba ◽  
Delphine D. Acar ◽  
Inge D.M. Roukaerts ◽  
Lowiese M.B. Desmarets ◽  
Bert Devriendt ◽  
...  

1992 ◽  
Vol 3 (suppl b) ◽  
pp. 123-127 ◽  
Author(s):  
Hans-Georg Klingemann ◽  
Heather Deal ◽  
Dianne Reid ◽  
Connie J Eaves

Despite the use of high dose chemoradiotherapy for the treatment of acute leukemia. relapse continues to be a major cause of death in patients given an autologous bone marrow transplant. Further augmentation of pretransplant chemotherapy causes life threatening toxicity to nonhematopoietic tissues and the effectiveness of currently available ex vivo purging methods in reducing the relapse rate is unclear. Recently, data from experimental models have suggested that bone marrow-derived lymphokine (IL-2)-activated killer (BM-LAK) cells might be used to eliminate residual leukemic cells both in vivo and in vitro. To evaluate this possibility clinically, a procedure was developed for culturing whole marrow harvests with IL-2 prior to use as autografts, and a number of variables examined that might affect either the generation of BM-LAK cells or the recovery of the primitive hematopoietic cells. The use of Dexter long term culture (LTC) conditions, which expose the cells to horse serum and hydrocortisone. supported LAK cell generation as effectively as fetal calf serum (FCS) -containing medium in seven-day cultures. Maintenance of BM-LAK cell activity after a further seven days of culture in the presence of IL-2 was also tested. As in the clinical setting. patients would receive IL-2 in vivo for an additional week immediately following infusion of the cultured marrow autograft. Generation ofBM-LAK activity was dependent on the presence of IL-2 and could be sustained by further incubation in medium containing IL-2. Primitive hematopoietic cells were quantitated by measuring the number of in vitro colony-forming progenitors produced after five weeks in secondary Dexter-type LTC. Maintenance of these 'LTC-initiating cells' was unaffected by lL-2 in the culture medium. These results suggest that LAK cells can be generated efficien tly in seven-day marrow autograft cultures containing IL-2 under conditions that allow the most primitive human hematopoietic cells currently detectable to be maintained.


Sign in / Sign up

Export Citation Format

Share Document